The US Food and Drug Administration’s (FDA) last week released a final guidance to assist the pharmaceutical industry in submitting comparability protocols for postapproval manufacturing changes. The ...
This Comparability Protocols training will provide you with the basics for use as well as provide you with new and expanded ways of using CPs. It will also assist you in finding ways to help shorten ...
The guidance discusses the implementation of CMC postapproval changes through a comparability protocol. On April 19, 2016, FDA issued guidance on how to implement a chemistry, manufacturing, and ...
ROCKVILLE, Md.--(BUSINESS WIRE)--April 22, 2014-- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has initiated manufacturing of BioThrax(R) (Anthrax Vaccine Adsorbed) consistency lots ...
Biologics have long been defined by their processes, raising complicated questions about how to assess the effect of manufacturing changes on product quality 1 —i.e., whether pre- and post-change ...
To establish whether clinical-product quality remains constant when making a process change can be a challenging exercise. Limited data availability further complicates the assessment of whether the ...